Chapter One
The Scope of Bipolar Disorders
Hagop S. Akiskal
International Mood Center
University of California at San Diego, USA
DIAGNOSTIC AND PUBLIC HEALTH ASPECTS
Recent advances in the epidemiology, psychopathology and pharmacotherapy of
bipolar disorders have led to a greater recognition of this illness in all of its varieties
(Akiskal et al., 2000). The lifetime risk for bipolar conditions is about 1% for the
core (bipolar I) phenotype, making it at least equal in prevalence to schizophrenia.
A higher percentage of acute psychiatric hospital admissions is now being
assigned to the category of mania, and the recognition of clinically attenuated
outpatient forms of the illness (soft bipolar spectrum) is increasing. The latter
(bipolar II and be ... read full excerpt from Bipolar Psychopharmacotherapy: Caring for the Patient ebook